DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL Stock

Certificat

DE000PC4JHX8

Market Closed - Boerse Frankfurt Warrants 03:40:13 2024-05-31 pm EDT
312 EUR -0.37% Intraday chart for DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL
1 month+3.02%
3 months+2.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 312 -0.37%
24-05-30 313.1 +0.26%
24-05-29 312.3 +0.30%
24-05-28 311.4 -1.13%
24-05-27 315 +0.40%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC4JHX
ISINDE000PC4JHX8
Date issued 2024-02-02
Cap 420 $
Last trading day 2025-12-19
Maturity 2025-12-19 (565 Days)
Parity 1 : 1
Emission price 293.2
Emission volume N/A
Payment day 2025-12-29
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 15.52 %
Sideways yield 18.39 %
Sideways yield pa 11.48 %
Outperformance point 497.2 $
Break even 339.65 €
Highest since issue 315.5
Lowest since issue 294.3
Distance Cap -17.88 $
Distance Cap %-4.45%
Max. earning 74.06
Max. earning % 23.66 %

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus